Porton Pharma Solutions Ltd operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Porton Pharma Solutions Ltd with three other
companies in this sector in CHINA :
Qianjiang Yongan Pharmaceutical Co Ltd
sales of 1.37 billion Chinese Renmimbi [US$201.39 million]
of which 50%
Huaren Pharmaceutical Co Ltd
(1.46 billion Chinese Renmimbi [US$214.83 million]
of which 91%
was Medicine Industry), and
Tibet Cheezheng Tibetan Medicine Co Ltd
(1.40 billion Chinese Renmimbi [US$206.12 million]
of which 100%
During the year ended December of 2019, sales at
Porton Pharma Solutions Ltd were 1.55 billion Chinese Renmimbi (US$227.96 million).
increase of 30.9%
versus 2018, when the company's sales were 1.18 billion Chinese Renmimbi.
Sales of Pharmaceutical R&d Production Service Cu saw an increase
11.0% in 2019, from
1.14 billion Chinese Renmimbi to 1.26 billion Chinese Renmimbi.
Not all segments of Porton Pharma Solutions Ltd experienced an increase in sales in 2019:
sales of Other Business fell 85.0% to 6.85 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).